ketanserin has been researched along with Intestinal Neoplasms in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Intestinal Neoplasms: Tumors or cancer of the INTESTINES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drozdov, I | 1 |
| Kidd, M | 1 |
| Gustafsson, BI | 1 |
| Svejda, B | 1 |
| Joseph, R | 1 |
| Pfragner, R | 1 |
| Modlin, IM | 1 |
1 other study available for ketanserin and Intestinal Neoplasms
| Article | Year |
|---|---|
Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines.
Topics: Cell Line, Tumor; Cell Proliferation; Homeostasis; Humans; Intestinal Neoplasms; JNK Mitogen-Activat | 2009 |